GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 90 filers reported holding GALENA BIOPHARMA INC in Q3 2014. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $42,000 | -25.0% | 119,722 | 0.0% | 0.00% | – |
| Q2 2016 | $56,000 | -65.6% | 119,722 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $163,000 | +6.5% | 119,722 | +14.9% | 0.00% | 0.0% |
| Q4 2015 | $153,000 | -7.3% | 104,175 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $165,000 | -6.8% | 104,175 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $177,000 | +38.3% | 104,175 | +13.4% | 0.00% | 0.0% |
| Q1 2015 | $128,000 | -6.6% | 91,865 | +1.5% | 0.00% | 0.0% |
| Q4 2014 | $137,000 | -27.9% | 90,531 | -1.8% | 0.00% | 0.0% |
| Q3 2014 | $190,000 | -32.1% | 92,182 | +0.8% | 0.00% | 0.0% |
| Q2 2014 | $280,000 | +33.3% | 91,472 | +8.8% | 0.00% | 0.0% |
| Q1 2014 | $210,000 | -46.4% | 84,036 | +6.4% | 0.00% | -50.0% |
| Q4 2013 | $392,000 | +142.0% | 78,987 | +10.5% | 0.00% | +100.0% |
| Q3 2013 | $162,000 | +174.6% | 71,473 | +167.7% | 0.00% | – |
| Q2 2013 | $59,000 | – | 26,694 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 375,000 | $855,000 | 0.93% |
| HIGHLAND CAPITAL MANAGEMENT LP | 800,000 | $1,824,000 | 0.12% |
| Alyeska Investment Group, L.P. | 780,000 | $1,778,000 | 0.07% |
| KMS FINANCIAL SERVICES, INC | 119,500 | $272,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 539,150 | $1,229,000 | 0.04% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 25,100 | $57,000 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 349,400 | $793,000,000 | 0.02% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 12,000 | $27,000 | 0.02% |
| Diversified Trust Co | 40,000 | $91,000 | 0.01% |
| PITTENGER & ANDERSON INC | 18,000 | $41,000 | 0.01% |